Portfolio Companies
Portfolio Companies
Chiesi Ventures invests in innovative biotech companies developing treatments for rare diseases.
![Mirum logo](https://chiesiventures.com/wp-content/uploads/2022/07/Mirum.webp)
MIRUM PHARMACEUTICALS
Mirum Pharmaceuticals is developing a compound, maralixibat, to treat Alagille syndrome (ALGS) and progressive familial intrahepatic cholestasis (PFIC), genetic liver disorders that affect primarily children.
IPO on NASDAQ
![CuraSen logo](https://chiesiventures.com/wp-content/uploads/2022/07/CuraSen.webp)
CURASEN
CuraSen Therapeutics is focused on the discovery and development of therapies to treat neurodegenerative diseases, including Parkinson’s Disease, Alzheimer’s Disease and less common neurodegenerative disorders.
![4DMT logo](https://chiesiventures.com/wp-content/uploads/2022/07/4DMT.webp)
4D MOLECULAR THERAPEUTICS
4D Molecular Therapeutics is a platform company focused on the discovery and development of novel adeno-associated virus (AAV) vectors for use in gene therapy products for the treatment of monogenetic disorders
IPO on NASDAQ
![velosbio logo](https://chiesiventures.com/wp-content/uploads/2022/07/velosbiologo.webp)
VELOSBIO
VelosBio, Inc. is an oncology focused biotechnology company which is developing antibody drug conjugates to target solid tumors and hematological cancers.
SOLD to MERK
![aura logo](https://chiesiventures.com/wp-content/uploads/2022/07/aura.webp)
AURA BIOSCIENCES
Aura Biosciences is an innovation-driven company focused on the development of drugs using tumor targeted Viral-like Nanoparticles.
IPO on NASDAQ
![sentien logo](https://chiesiventures.com/wp-content/uploads/2022/07/sentien.webp)
SENTIEN BIOTECH
Sentien Biotechnologies, Inc. is a late preclinical stage company developing novel approaches to cell therapy.
![kezar logo](https://chiesiventures.com/wp-content/uploads/2022/07/kezar.webp)
KEZAR LIFE SCIENCES
Kezar Life Sciences is a clinical-stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics that target protein homeostasis.
IPO on NASDAQ
![glycomine logo](https://chiesiventures.com/wp-content/uploads/2022/07/glycomine.webp)
GLYCOMINE
Glycomine is developing therapies for congenital disorders of glycosylation by combining replacement therapies with intracellular delivery vehicles.
![minorix logo](https://chiesiventures.com/wp-content/uploads/2022/07/minorix.webp)
MINORYX THERAPEUTICS
MINORYX specializes in developing innovative treatments for Inborn Errors of Metabolism, a group of rare diseases of genetic origin with high unmet medical need.
![Reneo logo](https://chiesiventures.com/wp-content/uploads/2022/07/Reneo.webp)
RENEO
Reneo Pharmaceuticals is a San Diego-based, private biotechnology company focused on the identification and development of novel treatments for orphan diseases.